IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernier-Fébreau, C.
Right arrow Articles by Le Bouguénec, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernier-Fébreau, C.
Right arrow Articles by Le Bouguénec, C.

 Previous Article  |  Next Article 

Infection and Immunity, October 2004, p. 6151-6156, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6151-6156.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Use of Deoxyribose by Intestinal and Extraintestinal Pathogenic Escherichia coli Strains: a Metabolic Adaptation Involved in Competitiveness

Christine Bernier-Fébreau,1 Laurence du Merle,1 Evelyne Turlin,2 Valérie Labas,3 Juana Ordonez,1,{dagger} Anne-Marie Gilles,2,4,{ddagger} and Chantal Le Bouguénec1*

Unité de Pathogénie Bactérienne des Muqueuses,1 Unité de Génétique des Génomes Bactériens,2 Laboratoire de Chimie Structurale des Macromolécules, Institut Pasteur,4 Laboratoire de Neurobiologie et Diversité Cellulaire, ESPCI, Paris, France3

Received 20 April 2004/ Returned for modification 24 May 2004/ Accepted 3 July 2004

We showed that the deoK operon, which confers the ability to use deoxyribose as a carbon source, is more common among pathogenic than commensal Escherichia coli strains. The expression of the deoK operon increases the competitiveness of clinical isolates, suggesting that this biochemical characteristic plays a role in host infectivity.

* Corresponding author. Mailing address: Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: 33 1 40 61 32 80. Fax: 33 1 40 61 36 40. E-mail: clb{at}pasteur.fr.

Editor: J. T. Barbieri

{dagger} Present address: Laboratorio Especial de Microbiologia, Instituto Butatan, 05503-900 Sao Paulo, SP, Brazil.

{ddagger} Present address: Unité de Génétique des Génomes Bactériens, Institut Pasteur, Paris, France.

Infection and Immunity, October 2004, p. 6151-6156, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6151-6156.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.